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Abstract
Background: IL-24 (melanoma differentiation-associated gene-7 (mda-7)), a member of the IL-10 cytokine family, possesses the
properties of a classical cytokine as well as tumor suppressor effects. The exact role of IL-24 in the immune system has not been
defined but studies have indicated a role for IL-24 in inflammatory conditions such as psoriasis. The tumor suppressor effects of
IL-24 include inhibition of angiogenesis, sensitization to chemotherapy, and p38 mitogen-activated protein kinase (MAPK)-
mediated apoptosis. Current knowledge on the regulation of IL-24 expression is sparse. Previous studies have suggested that
mRNA stabilization is of major importance to IL-24 expression. Yet, the mechanisms responsible for the regulation of IL-24
mRNA stability remain unidentified. As p38 MAPK is known to regulate gene expression by interfering with mRNA degradation
we examined the role of p38 MAPK in the regulation of IL-24 gene expression in cultured normal human keratinocytes.
Methodology/Principal Findings: In the present study we show that anisomycin- and IL-1b- induced IL-24 expression is
strongly dependent on p38 MAPK activation. Studies of IL-24 mRNA stability in anisomycin-treated keratinocytes reveal that
the p38 MAPK inhibitor SB 202190 accelerates IL-24 mRNA decay suggesting p38 MAPK to regulate IL-24 expression by
mRNA-stabilizing mechanisms. The insertion of the 39 untranslated region (UTR) of IL-24 mRNA in a tet-off reporter construct
induces degradation of the reporter mRNA. The observed mRNA degradation is markedly reduced when a constitutively
active mutant of MAPK kinase 6 (MKK6), which selectively activates p38 MAPK, is co-expressed.
Conclusions/Significance: Taken together, we here report p38 MAPK as a regulator of IL-24 expression and determine
interference with destabilization mediated by the 39 UTR of IL-24 mRNA as mode of action. As discussed in the present work
these findings have important implications for our understanding of IL-24 as a tumor suppressor protein as well as an
immune modulating cytokine.
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Introduction
The melanoma differentiation-associated gene-7 (mda-7) was
discovered through subtraction hybridization of cDNA libraries
prepared from melanoma cells [1]. The mda-7 gene was mapped
to a gene cluster on chromosome 1q32 together with IL-10
cytokine family members, IL-10, IL-19, IL-20. As mda-7 shares
considerable structural and sequence homology with IL-10
cytokine family members it was recognized as a member of this
family and renamed interleukin-24 (IL-24) [2]. IL-24 signals
through a heterodimeric receptor complex consisting of the IL-
20Rb subunit together with either the IL-20Ra subunit or the IL-
22Ra subunit. The IL-20Ra/IL-20Rb complex is shared with IL-
19 and IL-20 whereas the IL-22Ra/IL-20Rb complex is shared
with only IL-20 [3,4]. Binding of IL-24 as well as IL-19 and IL-20
to the receptor complexes results in signal transducer and activator
of transcription 3 (STAT3) -activation [4].
In general, research on IL-24 can be divided into two
categories: IL-24 as a classical cytokine with immune modulat-
ing properties or IL-24 as a protein with tumor suppressor
effects.
Forced IL-24 expression driven by a replication incompetent
adenoviral vector (ad.mda-7) has been demonstrated to selectively
induce growth suppression and apoptosis in a broad spectrum of
malignant cell lines in vitro while leaving normal cells unaffected
[5,6,7,8]. It appears that these effects are independent of the so far
identified IL-24 receptor complexes and JAK/STAT-signaling
[7]. Secreted IL-24 has been reported to be anti-angiogenic and to
sensitize tumor cells to radiation therapy and chemotherapy [9].
Furthermore, intra-tumoral administration of ad.mda-7 in a phase
I clinical trial showed evidence of clinical tumor suppressor effects
[10,11] and in support of the tumor suppressor effect of IL-24,
there appears to be an inverse correlation between IL-24
expression levels and melanoma progression [5,12].
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suppressor gene a few studies have investigated immune
modulating properties of IL-24 and its potential role in
inflammatory diseases [13,14,15]. In synovial fluid mononuclear
cells, IL-24 induced secretion of mononuclear chemoattractant
MCP-1 and in cultured PBMCs IL-24 induced expression of IL-6,
tumor necrosis factor-a (TNF-a), and interferon-c [14,15].
Increased expression of IL-24 has been reported in affected joints
of patients with rheumatoid arthritis and in lesional skin of patients
with psoriasis [15,16,17]. Keratinocytes express both the IL-
20Ra/IL-20Rb complex and the IL-22Ra/IL-20Rb complex and
stimulation of normal human epidermal keratinocytes (NHEK)
with IL-24 in vitro induced STAT3 activation [13,18]. Further-
more, IL-24 stimulation of NHEK resulted in altered keratinocyte
differentiation pattern, increased cell proliferation, and expression
of a number of psoriasis-related genes [13]. Taken together these
findings suggest a role for IL-24 in the pathogenesis of psoriasis
and other inflammatory conditions.
Cellular sources of IL-24 include, monocytes, T-cells [19],
NHEK [18], and melanocytes [5]. In peripheral blood mononu-
clear cells (PBMCs) IL-24 gene expression is induced by exposure
to concanavalin a- [3], lipopolysaccharide (LPS)-, or cytokines [19]
whereas in keratinocytes only IL-1b has been reported to induce
IL-24 mRNA expression [18]. At the transcriptional level IL-24
expression has been reported to be regulated by the transcription
factors activator protein-1 and CCAAT-enhancer-binding pro-
teins [20]. On the other hand, studies in melanoma cells and
PBMCs have suggested, that post-transcriptional gene regulation
by mRNA stabilization is of major importance to IL-24 gene
expression [19,21]. This is further supported by the fact that the 39
UTR of IL-24 mRNA contains mRNA-destabilizing AU-rich
elements (ARE) [21]. Yet the mechanisms responsible for the
regulation of IL-24 mRNA stability remain unidentified.
A study by Zhang et al reported ras oncogene-induced IL-24
expression indicating that IL-24 gene expression could be
regulated by MAPK signaling[22]. The p38 MAPK is known to
regulate the expression of cytokines through interfering with ARE-
dependent destabilization of cytokine-mRNA [23,24,25,26]. In a
previous study we identified p38 MAPK as crucial for the
expression of the IL-24-related cytokine, IL-20 [27]. As several of
the stimuli reported to induce IL-24 mRNA expression (e.g. IL-1b
in NHEK [18] and LPS in PBMCs [19]) are known p38 MAPK
activators we examined the role of p38 MAPK in the regulation of
IL-24 gene expression. In the present study we discover that IL-24
expression in NHEK is dependent on p38 MAPK activation, and
we demonstrate for the first time that p38 MAPK regulates IL-24
gene expression at a posttranscriptional level by interfering with
destabilization mediated by the 39 UTR of IL-24 mRNA.
The findings of the present study have important implications
for the understanding of IL-24 not only as an immune modulating
cytokine but also as a tumor suppressor gene.
Results
p38 MAPK Activation in NHEK Treated with Anisomycin
or IL-1b
Time course studies of p38 MAPK phosphorylation in NHEK
treated with anisomycin (300 ng/ml) or IL-1b (10 ng/ml) were
performed to assess their p38 MAPK activating capabilities.
Whole cell extracts were prepared and phosphorylation of p38
MAPK assessed by Western blotting (Figure 1). Stimulation for 10
minutes with anisomycin as well as IL-1b leads to increased p38
MAPK phosphorylation. In anisomycin-treated cells this increase
was maintained for at least 6–8 hours whereas in IL-1b-stimulated
cells p38 MAPK phosphorylation levels rapidly declined after 30
minutes. Thus, anisomycin stimulation of NHEK resulted in a
more pronounced and sustained p38 MAPK phosphorylation than
IL-1b stimulation as determined by Western blotting.
IL-24 mRNA Expression Is Induced by Anisomycin and IL-
1b in NHEK
Having established the p38 MAPK activation profile of
anisomycin and IL-1b we wanted to study the dynamics of IL-
24 mRNA expression in NHEK incubated with these two stimuli.
Therefore, time course studies on IL-24 mRNA expression in
NHEK stimulated with anisomycin (300 ng/ml) or IL-1b (10 ng/
ml) were conducted (Figure 2). IL-24 mRNA expression levels
were determined with quantitative reverse transcription polymer-
ase chain reaction (qRT-PCR). In anisomycin treated cells IL-24
mRNA levels were increased after one hour reaching a maximal
level of expression after 12 hours of stimulation. At this time point,
IL-24 mRNA levels showed an 80-fold induction compared with
non-stimulated cells (Figure 2A). Significantly increased levels of
IL-24 mRNA levels were observed in IL-1b-stimulated NHEK
after one and two hours (Figure 2B). Hereafter IL-24 mRNA levels
steadily declined. Maximal IL-24 mRNA expression was detected
after only 1 hour of IL-1b stimulation at which point IL-24
mRNA levels were 2.6 fold upregulated compared with cells not
stimulated. Thus, the observed induction of IL-24 mRNA
expression in NHEK treated with anisomycin or IL-1b corre-
sponded to the p38 MAPK activation profile of these stimuli
supporting a role for this kinase in the regulation of IL-24
expression.
The Dynamics of IL-24 Protein Expression in NHEK
Treated with Anisomycin
To study the kinetics of IL-24 protein expression, NHEK were
incubated with anisomycin (300 ng/ml) for 0, 6, 12, and 24 hours.
IL-24 protein levels were subsequently analyzed in whole cell
extracts as well as the supernatant using enzyme-linked immuno-
sorbent assay (ELISA) (Figure 3). Consistently, intracellular IL-24
protein levels remained below the detection limit of the IL-24
ELISA assay (data not shown). In the supernatant of medium-
incubated keratinocytes IL-24 protein remained constantly at a
low level whereas increased levels of IL-24 protein were detected
in the supernatant of anisomycin-stimulated NHEK at 12 and
Figure 1. Time course studies of p38 MAPK phosphorylation in
NHEK treated with anisomycin (300 ng/ml) and IL-1b (10 ng/
ml). Western blotting of equivalent amounts of whole-cell protein
extracts from NHEK treated with anisomycin or IL-1b for the indicated
time periods. The proteins were separated by SDS-PAGE, blotted onto a
nitrocellulose membrane and probed with an anti-phospho-p38 MAPK
antibody. Equal loading was confirmed by incubating with anti-total-
p38 MAPK. A representative gel of three different experiments is shown.
doi:10.1371/journal.pone.0008671.g001
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stimulated NHEK therefore, leads to an increased IL-24 protein
expression. The newly synthesized protein is not stored inside the
cell but immediately secreted.
p38 MAPK Is a Regulator of IL-24 Expression
To further investigate the role of p38 MAPK in IL-24
expression we used the p38 MAPK inhibitor SB 202190. First,
we investigated the efficacy of this inhibitor in disrupting p38
MAPK activity by preincubating NHEK with SB 202190 (10 mM)
before treatment with medium control or anisomycin (300 ng/ml)
for 30 minutes. For the assessment of p38 MAPK activation, the
phosphorylation of p38 MAPK-substrate mitogen activated
protein kinase-activated protein kinase 2 (MK2) was analyzed by
Western blotting (Figure 4A). Preincubation with SB 202190
resulted in complete abrogation of MK2-phosphorylation reflect-
ing complete disruption of p38 MAPK signaling by the inhibitor.
Next, we wanted to determine the impact of disrupted p38
MAPK activation on anisomycin- and IL-1b- induced IL-24
mRNA expression. Therefore, NHEK were incubated with or
without SB 202190 (10 mM) before treatment with medium or
anisomycin (300 ng/ml) for 6 hours (Figure 4B) or medium or IL-
1b for 1 hour (Figure 4C), respectively. Inhibition of p38 MAPK
before stimulation with anisomycin or IL-1b downregulated IL-24
mRNA expression to a level even below that observed in medium
treated NHEK. In a separate set of experiments the effect of SB
202190 on anisomycin-induced IL-24 protein expression was
investigated (Figure 4D), and in accordance with what we
observed at the mRNA-level, IL-24 protein concentration in the
supernatant of SB 202190-preincubated anisomycin-stimulated-
NHEK was even below what was observed in the supernatant of
NHEK incubated only with medium.
The p38 MAPK Regulates IL-24 mRNA Stability
Having discovered p38 MAPK as an important player in the
regulation of IL-24 expression we wanted to investigate the
underlying mechanisms. Therefore, we analyzed the impact of p38
MAPK inhibition on IL-24 mRNA stability. First, NHEK were
incubated with anisomycin (300 ng/ml) for two hours, thus
allowing activation of p38 MAPK and induction of IL-24 mRNA
expression. Then cells were added either medium (control), the
inhibitor of transcription actinomycin D (7.5 mg/ml) or the p38
MAPK inhibitor, SB 202190 (10 mM). Cells were subsequently
harvested at 30 minutes intervals for up to 180 minutes and IL-24
mRNA expression determined (Figure 5A). Inhibition of tran-
scription with actinomycin D did not lead to a downregulation of
IL-24 mRNA levels throughout the 180 minutes of the study
suggesting that IL-24 mRNA is relatively stable in anisomycin-
stimulated NHEK. However, inhibition of p38 MAPK with SB
202190 resulted in a significant downregulation of IL-24 mRNA
after 90 minutes (34 fold vs 134 fold in control). Simultaneous
inhibition of transcription (actinomycin D) and the p38 MAPK
(SB 202190) resulted in a downregulation of IL-24 mRNA
expression comparable to that achieved by SB 202190 alone
(data not shown). Hence, p38 MAPK appears to be essential for
IL-24 mRNA stability. As an internal assay control TNF-a mRNA
expression was also determined. Incubation with SB 202190 did
not affect TNF-a mRNA expression levels significantly whereas
degradation of TNF-a mRNA could be detected after 120 minutes
in cells incubated with actinomycin D (Figure 5B).
As control NHEK were also incubated with actinomycin D
(7.5 mg/ml) for one hour before stimulation with anisomycin
(300 ng/ml) for 2 hours (Figure 5C). In this setup preincubation
with actinomycin D before treatment with anisomycin downregulat-
e dI L - 2 4m R N Al e v e l st o0 . 3 5f o l dc o m p a r e dw i t h1 4 . 5f o l di n
anisomycin-stimulatedNHEKnotpreincubatedwithactinomycinD.
Thus, as transcription was blocked before anisomycin stimulation IL-
24 mRNA rapidlydecayed reflecting a short half-lifeof IL-24 mRNA
in cells where p38 MAPK activation has not been induced.
Figure 3. IL-24 protein expression in the supernatant of NHEK
treated with medium control or anisomycin (300 ng/ml). NHEK
were cultured in the presence or absence of anisomycin for up to
24 hours. IL-24 protein levels in the supernatant were analyzed by
ELISA. IL-24 protein concentrations were normalized to the calculated
total protein concentration of the whole cell extracts.*p,0.05
compared with cells harvested before stimulation (0 hours) (n=5
cultures). Points indicate mean 6 SEM.
doi:10.1371/journal.pone.0008671.g003
Figure 2. Time course studies of IL-24 mRNA expression. NHEK
were incubated with (A) anisomycin (300 ng/ml) or (B) IL-1b (10 ng/ml)
for the indicated time periods and IL-24 mRNA expression levels (relative
to housekeeping gene 18srRNA) were determined using quantitative RT-
PCR. *p,0.05comparedwith cellsharvested before stimulation(0 hours)
(A, n=6 cultures, B, n=5 cultures). Bars indicate mean 6 SD.
doi:10.1371/journal.pone.0008671.g002
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and p38 MAPK-Induced Stabilization
p38 MAPK stabilizes mRNAs by interfering with rapid
degradation imposed by AU-rich elements in their 39 UTR. The
IL-24 39 UTR contains three AUUUA motifs typical for AU-rich
elements (Figure 6A). To test if indeed the IL-24 39 UTR harbors
the elements mediating rapid degradation and p38 MAPK-
dependent stabilization, a tet-off reporter plasmid was constructed.
The plasmid expresses the stable b-globin mRNA (t/2.10 h, not
shown) with the IL-24 39 UTR inserted downstream of the stop
codon (Figure 6A). The kinetics of degradation of the chimeric
mRNA and of the b-globin mRNA without insertion was
determined in HeLa cells by qRT-PCR of RNA isolated at
different time points following inhibition of transcription by
doxycycline. The half life of the chimeric mRNA was also
determined by Northern blot (Figure 6C). Two mRNA species
were detected, probably reflecting two different polyadenylation
sites. Both species are rapidly degraded, demonstrating that the IL-
24 39 UTR exerts effective destabilization.
The effect of p38 MAPK activation on degradation of the
chimeric mRNA was assayed by co-expressing a constitutively
active mutant of the MAPK kinase MKK6 (MKK62E). MKK6
selectively activates p38 MAPK [28] and has been used in the past
to show p38 MAPK-dependent stabilization of several mRNAs
containing AU-rich elements [24,25]. MKK62E co-expression
caused a marked stabilization of the b-globin-IL-24 chimeric
mRNA. Hence, we conclude that rapid degradation of IL-24
mRNA under basal conditions and stabilization by p38 MAPK are
dependent on the 39 UTR of IL-24.
Discussion
In the present study we investigated the ability of anisomycin
and IL-1b to induce p38 MAPK mediated IL-24 expression.
Anisomycin is a specific p38 MAPK and JNK activator [29]
whereas IL-1b in addition to p38 MAPK and JNK also activates
several other signaling pathways including ERK1 and 2 [30], and
IKK-b [27]. We discovered a correlation between the level of p38
MAPK activation and IL-24 mRNA expression. Inhibition of p38
MAPK activation with the p38 MAPK inhibitor SB 202190
blocked IL-24 mRNA and protein expression in both stimulated
and un-stimulated cells, demonstrating the importancy of this
kinase in IL-24 expression. These findings were also confirmed by
separate sets of experiments where NHEK were stimulated with
12-O-Tetradecanoylphorbol-13-acetate (data not shown).
Figure 4. Inhibition of p38 MAPK activation abrogates IL-24 expression. (A) Whole cell extracts were prepared from NHEK incubated with or
without (control) anisomycin (300 ng/ml) for 30 minutes in the absence or presence of the 38 MAPK inhibitor SB 202190 (10 mM). Proteins were
separated by SDS-PAGE. After electroblotting, separated proteins were probed with anti-phospho-MK2 (recognizing the phosphorylated form of MK2
isoforms 1 and 2) and anti-total p38 MAPK. A gel representative of three different experiments is shown. NHEK were cultured with or without SB 202190
(10 mM) for 30 minutes before incubation with (B) anisomycin (300 ng/ml) or medium control for 4 hours or (C) IL-1b (10 ng/ml) or medium control for
2 hours. Total RNA was extracted and IL-24 mRNA (relative to housekeeping gene 18 s RNA) levels were determined. *p,0.05 compared with medium
control (n=5 cultures). Bars indicate mean 6 SD. (D) NHEK were cultured in the presence or absence of SB 202190 (10 mM) with medium control or
anisomycin (300 ng/ml) for 18 hours. Using ELISA IL-24 concentration in the supernatants was determined and subsequently normalized to the total
protein concentration of whole cell extracts. *p,0.05 compared with medium control (n=5 cultures). Bars indicate mean 6 SD.
doi:10.1371/journal.pone.0008671.g004
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PBMCs [19] we found IL-24 mRNA to be a relatively stable
molecule in keratinocytes stimulated with anisomycin. However,
when p38 MAPK was inactivated with SB 202190 the IL-24
mRNA half-life was significantly reduced reflecting increased
mRNA instability and an accelerated IL-24 mRNA decay. Hence,
our results suggested p38 MAPK to regulate IL-24 expression by
mRNA-stabilizing mechanisms. It is a well established fact that p38
MAPK control expression of cytokines, growth factors or proto-
oncogenes through regulation of mRNA decay [23]. The p38
MAPK controls the binding affinity of ARE-binding proteins either
directly or through activation of downstream kinases (e.g. MK2,
MK3 and the MAPK-interacting kinases) [25,26]. Altered binding
of this class of proteins to ARE in the 39 UTR of mRNA ultimately
leads to increased stability of a specific mRNA and expression of its
encoded protein [31]. In keeping with a previous study on
melanoma cells [21], insertion of the 39 UTR of IL-24 mRNA
induced degradation of the b-globin reporter mRNA in our assay.
Selective activation of p38 MAPK by expressing a constitutively
active form of the p38-selective MAPK kinase 6 (MKK6) resulted in
increased stability of the IL-24 39 UTR-b-globin reporter mRNA
assay. Taken together these findings demonstrate that p38 MAPK
regulates IL-24 mRNA expression by interfering with destabiliza-
tion exerted by the 39 UTR of IL-24 mRNA.
IL-24 expression can be detected in melanocytes and early
melanomas but expression levels decrease as melanomas advance
becoming virtually undetectable in metastatic disease [5,12].
Furthermore, induction of terminal differentiation in melanoma
cells with fibroblast interferon and mezerein lead to an increase in
IL-24 mRNA expression primarily through an increased stability
of IL-24 mRNA [1,21]. p38 MAPK is known to be involved in the
growth and differentiation of normal cells [32]. In melanoma cells
p38 MAPK has been reported to mediate a-melanocyte
stimulating hormone-induced differentiation [33,34]. Thus, the
gradual loss of IL-24 expression as melanocytes transform into
aggressive melanoma cells and the regained expression of IL-24 in
terminally differentiated melanoma cells may well be explained by
differentiation-associated alterations in the activity of p38 MAPK,
its downstream kinases and RNA-binding proteins.
Intriguingly, IL-24 has been demonstrated to exert its effects in
malignant cells by inducing cellular stress leading to p38 MAPK
activation [8,35,36]. IL-24-induced p38 MAPK activation pro-
moted survival of chronic lymphocytic leukaemia B-cells [36]
whereas ad.mda-7-induced p38 MAPK activation in melanoma
cells lead to apoptosis [8]. These findings correspond with the fact
that p38 MAPK primarily is considered a tumor suppressor
pathway although in certain settings it may also promote the
opposite [37]. Recently, IL-24 was reported to induce its own
expression in cancer cells through mRNA stabilization [38]. It was
suggested that IL-24 through a positive autocrine loop induced
amplification of its own expression as well as cellular stress leading
to apoptosis of malignant cells [38]. Our findings complete this
loop: Hence, forced expression with ad.mda-7 in malignant cells
leads to cellular stress and p38 MAPK activation which in turn
stabilizes endogenous IL-24 mRNA further enhancing IL-24
expression and cellular stress eventually resulting in apoptosis.
p38 MAPK is assumed to be of major importance in the
inflammatory response and increased activation of this pathway
and its downstream kinases has been reported in inflammatory
conditions such as psoriasis [39,40]. In accordance, the expression
of several cytokines assumed to play a role in the pathogenesis of
psoriasis (i.e. IL-20[27], TNF, IL-8, and IL-6) are p38 MAPK-
regulated. Thus, the increased expression of IL-24 mRNA in
lesional psoriatic skin [16,17] corresponds nicely with the
increased activation of p38 MAPK in psoriasis and indicates a
role for IL-24 in the pathogenesis of psoriasis.
However, it appears that many of the characteristics of IL-24 are
shared with other members of the IL-10 family, in particular IL-20.
For instance, IL-20 and IL-24 share receptor complexes, have
considerablesequencehomology,activateSTAT3,andhave similar
effects on keratinocytes (induces proliferation, alter differentiation
pattern and expression of overlapping sets of genes). IL-20 and IL-
24 expression are induced by the same stimuli in identical cell types,
i.e. IL-1b in keratinocytes [18] and LPS in monocytes [19].
Furthermore, IL-20 mRNA also contains several AREs in its 39
UTR [41], and IL-20 expression is also strongly dependent on p38
MAPK activation [27]. Altogether, these findings point to
redundancy among the IL-10 family members, which must be
considered when designing drugs targeting these cytokines for the
treatment of inflammatory conditions. In case of explicit redun-
Figure 5. p38 MAPK regulates IL-24 expression at a posttran-
scriptional level. ( Aa n dB )N H E Kw e r ep r e - s t i m u l a t e dw i t h
anisomycin (300 ng/ml) for 2 hours at which point medium (control),
the transcription inhibitor actinomycin D, or SB 202190 were added to
the cultures. Cells were then harvested at 30 minute intervals, total RNA
extracted and (A) IL-24 and (B) TNFa-mRNA levels (relative to 18 s RNA)
were determined. *p,0.05 compared with control (n=5). Points
indicate mean 6 SD. (C) As control NHEK were pre-incubated with or
without actinomycin D for one hour before treatment with medium or
anisomycin (300 ng/ml) for another 2 hours. Total RNA was extracted
IL-24 mRNA levels (relative to 18 s RNA) were determined. *p,0.05
compared with medium control (n=4). Bars indicate mean 6 SD.
doi:10.1371/journal.pone.0008671.g005
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expression could prove more efficaciousthan targetingthe cytokines
individually. Our findings point to p38 MAPK and its downstream
kinases as potential candidates for this.
In summary, we identify p38 MAPK as a regulator of IL-24
expression and determine interference with destabilization medi-
ated by the 39 UTR of IL-24 mRNA as mode of action. These
findings help us to understand the altered expression pattern of IL-
24 in malignant tissues, and they provide new important
knowledge if IL-10 cytokine family members are to be targeted




NHEK were obtained by trypsinization of skin removed from
patients undergoing plastic surgery [42]. First passage keratino-
cytes were grown in serum-free keratinocyte growth media with
human recombinant epidermal growth factor, bovine pituitary
extract and gentamicin (Gibco/Invitrogen, Carlsbad, CA). Fresh
media was added every second day and cells were grown to
approximately 60% confluency. At this point the growth factor
supplemented media was changed to non-growth factor supple-
mented media. After another 24 hours the cells were stimulated.
Anisomycin was purchased from Sigma-Aldrich (St. Louis, MO)
and IL-1b was from RnD Systems (Abingdon, UK). As medium
control sterile phosphate-buffered saline (Gibco/Invitrogen,
Carlsbad, CA) with 0.15% bovine serum albumin was used. The
keratinocytes were grown in 6-well plates (TPP, Trasadingen,
Switzerland) at 37uC and 5% CO2. In selected experiments cells
were incubated with inhibitor of the p38 MAPK pathway, SB
202190 (Calbiochem, San Diego, CA). SB 202190 was added 30
minutes prior to stimulation of the keratinocytes. Inhibition of
transcription was achieved by incubating cells with actinomycin D
(Calbiochem, San Diego, CA) 60 minutes prior to stimulation.
This study was conducted in accordance with the Helsinki
Declaration principles. The medical ethical committee of Aarhus
University Hospital approved the study. Informed, written consent
was obtained from each patient.
Figure 6. The 39 UTR of IL-24 mRNA mediates rapid degradation and p38 MAPK-induced stabilization of a reporter mRNA. (A)
Scheme of IL-24 mRNA and insertion of its 39 UTR into tet-off vector-expressed b-globin mRNA. The three AUUUA-motifs (indicated by arrows) are
displayed. (B) HeLa cells were transfected with plasmids expressing the b-globin mRNA without insertion (b-G) or with the IL-24 39 UTR inserted (b-G-
IL24) and with empty vector or a plasmid expressing constitutively active MKK6 (MKK62E). Total RNA was isolated at the indicated times after stopping
transcription with doxycycline (3 mg/ml). mRNA amounts were determined by qRT-PCR (means 6 SD of triplicates) and expressed relative to the
amount at the time of doxycycline addition (=100%). (C) mRNAs from a separate experiment carried out as described for (B) were analyzed by
Northern blot with a b-globin antisense probe. Two species of the hybrid mRNA (b-G-IL24 a and b) were detected. Ethidium bromide staining of 28 S
rRNA is shown as a loading control. Similar results were obtained in two separate experiments.
doi:10.1371/journal.pone.0008671.g006
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The cell supernatant was discarded and while on ice the
keratinocytes were washed once in ice-cold sterile phosphate-
buffered saline (Gibco/Invitrogen, Carlsbad, CA). RNA was
purified with SV Total RNA Isolation System (Promega, Madison,
WI). Briefly; 175 ml of SV RNA Lysis Buffer was added and lysates
prepared by manually scraping the bottom of the wells. 350 mlo f
SV RNA Dilution Buffer was added and tubes inverted 10 times to
mix. Samples were then put on a heating block for three minutes
at 70uC and afterwards centrifuged at 13000 g, at room
temperature for 10 minutes. Then the supernatant was transferred
to a new set of sterile eppendorf tubes. 200 ml of 96% ethanol was
added to the supernatant and mixing was done by pipetting. The
mixture was then transferred to spin baskets attached to a Vac-
Man with Mini-Prep Vacuum Adapters (Promega, Madison, WI).
Total RNA was purified according to the vacuum protocol, as
described by the manufacturer. Ultimately, RNA was dissolved in
RNase/DNase free water and stored at 280uC until further use.
Quantitative RT-PCR
For reverse transcription, Taqman Reverse Transcription
reagents (Applied Biosystems, Foster City, CA) were used
according to manufacturer’s instructions using random hexamers
as primers. Reverse transcription thermal cycling was performed
on a Peltier Thermal Cycler-200 (MJ Research, Inc. Waltham,
MA). Conditions were a 25uC incubation step for 10 minutes,
followed by a 48uC reverse transcription step for 30 minutes and
finally a 95uC reverse transcriptase inactivation step for 5 minutes.
cDNA was stored at 280uC. Primers and probes were purchased
from Applied Biosystems (Foster City, CA). IL-24, IL-20, and
TNF-a mRNA expression was determined with a Taqman 20X
Assays-On-Demand (FAM-labelled MGB-probes) gene expression
assay mix (assay ID: IL-24: Hs01114274_m1; IL-20:
Hs00218888_m1; TNFa: Hs00174128_m1). The housekeeping
gene used for normalization was 18s rRNA (assay ID:
Hs99999901_s1). The expression of each gene was analyzed in
triplicates. Reaction volume was 25 ml, consisting of 11.25 ml
cDNA diluted in RNasefree-water, 1.25 ml 20X primer/probe mix
and 12.5 ml Taqman 2X Universal PCR Master Mix (Applied
Biosystems, Foster City, CA). PCR conditions were 2 minutes at
50uC, 10 minutes at 95uC followed by 50 cycles of 15 seconds at
95uC and 60 seconds at 60uC. Real-time PCR machine was a
Rotorgene-3000 (Corbett Research, Sydney, Aus). Relative gene
expression levels were determined by using the relative standard
curve method as previously described [43].
Whole Cell Extracts for ELISA
While the cells were on ice, the supernatant was transferred to
sterile eppendorf tubes and snap frozen in liquid nitrogen. The
keratinocytes were washed twice in ice-cold sterile phosphate-
buffered saline and snap frozen in liquid nitrogen. Supernatant
and cells were stored at 280uC until further use. Whole cell
extracts were prepared from the keratinocytes. The six-wells were
placed on ice and 120 ml cell lysis buffer (20 mM Tris-Base
pH 7.5, 150 nM NaCl, 1 nM EDTA, 1 mM EGTA, 1% Triton
X-100, 2.5 mM sodium pyrophosphate, 1 mM b-Glycerolpho-
sphate, 1 mM sodium orthovanadate, 1 mM PMSF and 16
Complete protease inhibitor cocktail (Roche, Mannheim, Ger-
many) were added to each well. The bottom of the wells was
manually scraped with a rubber policeman and the samples were
transferred to sterile eppendorf tubes. The samples were then
sonicated and centrifuged at 10000 g for 10 minutes at 4uC after
which the supernatant constitutes the cell lysate. Protein
concentrations were determined with Bradford analysis using
albumin for the standard curve. Samples were stored at 280uC
until ELISA analysis.
IL-24 ELISA
To quantify the concentration of IL-24 the human IL-24
DuoSet ELISA Development kit from R&D Systems, Abingdon,
UK, was used according to the manufacturerer’s instructions.
Briefly; Maxisorp 96 well flat-bottom plates (NUNC, Roskilde,
Denmark) were coated with 100 ml of capture antibody and
incubated overnight at room temperature. Plates were then
blocked with 300 ml of reagent diluent (1% BSA in PBS) and
incubated for 1 hour at room temperature. Triplicates of 100 mlo f
samples and standards were added and plates were incubated for
2 hours at room temperature. A seven point standard curve using
2-fold serial dilutions and a high standard of 4000 pg/ml was
used. Plates were then incubated with 100 ml of Detection
Antibody for 2 hours at room temperature. 100 ml of Streptavi-
din-HRP was added and plates were incubated for 20 minutes at
room temperature in the dark. Plates were then incubated with
100 ml of Substrate Solution in the dark at room temperature for
20 minutes. 50 ml of stop solution was added and the optical
density was determined at 450 nm with a reference reading at
630 nm. All steps were followed by washing plates three times with
wash buffer.
Western Blot Analysis
Cells were washed in ice cold phosphate-buffered saline and
lysed in a buffer containing 50 mM Tris-HCL, pH 6.8, 10 mM
ditiothretiol, 10 mM b-glycerophosphate, 10 mM sodium fluo-
ride, 0.1 mM sodium orthovanadate, 10% glycerol, 2.5% SDS
added PMSF and a cocktail of proteinase inhibitors (Roche,
Mannheim, Germany). The lysates were boiled for 3 minutes and
while on ice incubated with benzon nuclease for 30 minutes and
finally centrifuged for 13600 g for 3 minutes. The supernatant was
transferred to a fresh eppendorf tube and stored at 280Cu until
further use. Protein concentrations were determined with Bradford
analysis using albumin for the standard curve and equal amounts
of whole cell extracts were separated with SDS-PAGE and blotted
onto nitrocellulose membranes. Membranes were incubated with
primary antibodies and detected by horseradish peroxidase-
conjugated secondary antibodies in a standard ECL reaction
(GE Healthcare, Wessling, Germany). Primary anti-phospho-p38
MAPK, -phospho-MK2 (Thr334), and -p38 MAPK antibodies,
and secondary anti-rabbit antibody were from Cell Signaling
Technology, Beverly, MA. A pre-stained marker (Invitrogen,
Carlsbad, CA) and a biotinylated marker from Cell Signaling
Technology were used for estimation of protein weight.
Reporter Assays for mRNA Degradation
The 39 UTR of IL-24 mRNA was analyzed for its effect on
degradation of the stable b-globin mRNA following previously
described protocols [31]. Briefly, a 39 UTR fragment covering nt
895 to 1679 of human IL-24 mRNA (accession No. NM_006850)
was obtained by RT-PCR with BglII-flanked primers (specific
sequences: 59 aatgtctagaccaggacct (sense), 59 agcagggaatgtcatcaca
(antisense), and cloned into the BglII-site of plasmid ptet-BBB, a tet-
off vector which contains genomic sequences of rabbit b-globin
[44]. HeLa cells constitutively expressing the tetracycline-con-
trolled transactivator protein [45] were transfected by the calcium
phosphate method, and the degradation kinetics of plasmid-
expressed b-globin mRNA containing the IL-24 39 UTR was
determined using the tet-off system. Northern blot analysis of total
RNA obtained after different times of inhibiting transcription by
doxycycline was performed as described [23]. Results were
Regulation of IL-24 Expression
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autoradiographs with suitable exposure times to avoid signal
saturation. Samples of RNA were reverse-transcribed and real-
time PCR was performed with a custom Taqman gene expression
assay for rabbit b-globin mRNA (Applied Biosystems, Foster City,
CA) according to the manufacturer’s recommendations. Results
were normalized to GAPDH mRNA (assay ID: Hs99999905_m1).
Statistical Analysis
The significance of differences in figure 3, 5A, and 5B IL-24
mRNA levels and protein levels were determined by a paired t-test
(two tailed). To test for normal distribution a probability test was
made. In figure 2, 4 and 5c, 0h samples and medium control
samples, respectively, was for every culture arbitrarily set to 1. All
other samples were indicated as fold change compared with 0 h or
medium control, respectively. For statistical analysis a two tailed
one sample T-test (comparing the mean fold change with a
hypothetical mean of 1) was used.
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